ivosidenib and Anemia--Refractory

ivosidenib has been researched along with Anemia--Refractory* in 1 studies

Other Studies

1 other study(ies) available for ivosidenib and Anemia--Refractory

ArticleYear
First Drug Approved for Patients with Refractory AML and Mutation in the IDH1 Gene.
    The American journal of nursing, 2018, Volume: 118, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory; Antineoplastic Agents; Female; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Pyridines

2018